Titan Biotech has informed that the trading window for dealing in the securities of the Company shall remain closed from Thursday, the 01st day of January, 2026 till the expiry of 48 hours after the declaration of un-audited standalone & consolidated financial results of the company for the third quarter and nine months ending on 31st December, 2025 for all Designated Persons, their Immediate Relatives and all Connected Persons covered under the Code. The date of the Board Meeting for consideration & approval of the un-audited standalone & consolidated financial results of the Company for the third quarter and nine months ending on 31st December, 2025, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
